Meta Platforms’ revenues of $40.6 billion in Q3 reflected a 19% y-o-y rise, driven by a 7% rise in ad impressions and an 11% ...

Meta’s growth is normalizing with decelerating ad revenue, but FY2024 guidance shows promise. See why META stock is still a ...

Despite the recent rally, we believe that the stock remains cheaply valued compared ... upside potential of +19.8% to our ...

With its 3-star rating, we believe Meta’s stock is fairly valued compared with our long-term fair value estimate of $560 per share, which represents an enterprise value of 13 times our 2024 adjusted ...

Loop Capital analyst Rob Sanderson raised the firm’s price target on Meta Platforms (META) to $655 from $575 and keeps a Buy rating on ...

Shares of Meta Platforms (META) took a breather last week after surging over 500% in the last two years. The social media ...

SoftBank CEO Masayoshi Son recently told investors that he thinks Nvidia stock is undervalued. Masayoshi Son is one of the most celebrated investors in modern history. As CEO of Japanese holding ...

Meta Platforms (META) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock ...

The S&P 500 has become more expensive since 2016 as the weightings of the technology sector and so-called Big Tech companies have increased in the index, according to DataTrek. Chip maker Nvidia has ...

It's set to be another volatile trading session for Trump Media & Technology Group (DJT), the home of Republican nominee Donald Trump's social media platform Truth Social.

The Russell 2000 Index measures the performance of 2,000 smaller companies listed in the US stock market. The gauge of ...

(RTTNews) - Arcus Biosciences, Inc. (RCUS), Tuesday announced results from part 1 of ARC-10, evaluating the effects of the combination of Domvanalimab and Zimberelimab versus Zimberelimab or ...